Brief: Ceapro Presents Positive Results From Avenanthramides Study
05/06/2019 13:20
June 5 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO PRESENTS POSITIVE RESULTS FROM AVENANTHRAMIDES
STUDY AT
THE 2019 AMERICAN SOCIETY OF SPORTS MEDICINE MEETING
* CEAPRO INC - RESULTS SHOWED THAT HIGH REGIMEN OF
AVENANTHRAMIDES
COULD INHIBIT EXERCISE-INDUCED COLONY STIMULATING FACTORS
Source text for Eikon: ID:nGNXc8ypWK
Further company coverage: CZO.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases